Resolute Science

Recent Finacing

Equity

Recent Raise

Undisclosed

Resolute Science, a preclinical biotech developing a modular MAC‑TAC (macrophage-targeted conjugate) platform to deliver cytotoxic and radiotherapeutic payloads into tumors; lead RS-5 (MMAE) shows efficacy in multiple tumor models.

Founded 2020

California, United States

1-10

Private

resolutescience.com

Highlights

Focus Areas

Biotechnology

Oncology

Pharmaceutical

Recent Investors

Financials

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Resolute Science.